Cargando…
NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma
Medulloblastoma (MB) is the most common malignant solid paediatric brain tumour. The standard treatment for MB is surgical resection of the tumour, radiation and chemotherapy. This therapy is associated with high morbidity and adverse side effects. Hence, more targeted and less toxic therapies are v...
Autores principales: | Frisira, Eleni, Rashid, Fatima, Varma, Swastina Nath, Badodi, Sara, Benjamin-Ombo, Valentine Ayodele, Michod, David, Niklison-Chirou, Maria Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795856/ https://www.ncbi.nlm.nih.gov/pubmed/31619667 http://dx.doi.org/10.1038/s41419-019-2026-y |
Ejemplares similares
-
A novel proteasome inhibitor NPI-0052 as an anticancer therapy
por: Chauhan, D, et al.
Publicado: (2006) -
Glutamine metabolism, the Achilles heel for medulloblastoma tumor
por: Niklison-Chirou, Maria Victoria
Publicado: (2018) -
Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment?
por: McNamee, Megan Jessica, et al.
Publicado: (2021) -
Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
por: Bevacqua, Emilia, et al.
Publicado: (2021) -
TAp73 is a marker of glutamine addiction in medulloblastoma
por: Niklison-Chirou, Maria Victoria, et al.
Publicado: (2017)